Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role Podcast

By AHRMM

Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.

Related Resources

Letters/Comments
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult.
Advisories
Statement on Pricing Transparency
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<
Advisories
CMS Releases Proposed Rule for Hospital Value-Based Purchasing Program
The Patient Protection and Affordable Care Act of 2010 (ACA) requires the Secretary of Health and Human Services to establish a VBP program t
Advisories
FDA Releases Proposed Rule on Unique Device System for Medical Devices
The FDA UDI ruling has finally arrived - the proposed rule has published.
Advisories
Special Fraud Alert: Physician-Owned Entities
This Special Fraud Alert focuses on the specific attributes and practices of PODs that OIG believes produce substantial fraud and abuse risk and pose…
Supply Chain Strategies & Solutions Article
The Future for Effective Healthcare Supply Change Is Balancing Cost, Quality, and Outcomes
Supply chain must play an integral role in the care delivery process through cross-departmental partnerships that support evidence-based valu